Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
60.5M
-
Number of holders
-
235
-
Total 13F shares, excl. options
-
48.1M
-
Shares change
-
+1.2M
-
Total reported value, excl. options
-
$6.4B
-
Value change
-
+$163M
-
Put/Call ratio
-
0.85
-
Number of buys
-
137
-
Number of sells
-
-99
-
Price
-
$133.25
Significant Holders of Twist Bioscience Corp - Common Stock (TWST) as of Q2 2021
288 filings reported holding TWST - Twist Bioscience Corp - Common Stock as of Q2 2021.
Twist Bioscience Corp - Common Stock (TWST) has 235 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48.1M shares
of 60.5M outstanding shares and own 79.53% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (5.05M shares), Capital World Investors (4.52M shares), VANGUARD GROUP INC (4.18M shares), BlackRock Inc. (3.85M shares), Sumitomo Mitsui Trust Holdings, Inc. (2.53M shares), Nikko Asset Management Americas, Inc. (2.52M shares), Invesco Ltd. (1.93M shares), JPMORGAN CHASE & CO (1.78M shares), Allianz Asset Management GmbH (1.65M shares), and CREDIT SUISSE AG/ (1.42M shares).
This table shows the top 235 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.